Aesthetics

This week, consumer magazines highlight stress-related hair loss, post-melanoma skin protection, and more.

This week in aesthetics, we highlight this month’s “Meet the Aesthetic Expert” column with Will Kirby, DO, FAOCD, Michael Kluska, DO, discusses Evoke by InMode in his monthly technology review, and more.

In this month's Cosmetic Conundrums column, Chief Medical Editor of Dermatology Times®, Zoe Diana Draelos, MD, answers a few common questions on how to treat eye issues.

In this monthly technology review, Michael Kluska, DO, discusses Evoke by InMode, including cost, ROI, patient protocols, and treatment frequency.

In this month's Legal Eagle article, David J. Goldberg, MD, JD, examines physicians being sued for using injectables for off-label procedures, such as for oily skin.

Experts evaluate the efficacy, safety of regenerative skin care products.

Ava Shamban, MD, discusses microneedling differentiators using the Vivace Microneedle RF device, combination therapies, and the importance of social media partnerships.

In this month’s "Meet the Aesthetic Expert" column, Will Kirby, DO, FAOCD, talks with Megan Driscoll, CEO and founder of public relations and digital communications agency, EvolveMKD, about the ever-changing aesthetic specialty, reaching the younger generations, and starting her own company.

This week, consumer magazines highlight the Botox lip flip vs filler, #SkincareTwitter, and more.

This week in aesthetics, we highlight a new survey quantifying the QoL data for transmen post gender-affirming surgery, abdominal contouring using HIFEM and RF combination therapy, and more.

A recent study examined cetirizine 1% cream as treatment in male patients diagnosed with androgenetic alopecia.

New study data presented at EADV demonstrated an association between COVID-19 severity in male patients and the sex hormone androgen.

A comparative study examines Fractional CO2 and Nd‐YAG laser effectiveness in keloid management.

Allergan Aesthetics, an AbbVie company, announces the acquisition of Soliton and its newly launched RAP device, further expanding the company’s body contouring portfolio.

Sunscreen is a necessary preventive tool. However, there are concerns about UV agent absorption, environmental impact, and possible correlations with frontal fibrosing alopecia (FFA). Here is a look at whether those worries are justified by research.

Allergan Aesthetics, an AbbVie company, announces the acquisition of Soliton and its newly launched RAP device, further expanding the company’s body contouring portfolio.

A recent study looks at the safety and efficacy of HIFEM and RF combination therapy for fat reduction.

A new survey from the University of California is the first to quantify the quality-of-life data for transgender men who undergo gender-affirming surgery.

This week, consumer magazines highlight scalp skin care for alopecia patients, neck lifts for the younger generations, and more.

This week in aesthetics, we highlight PRP topical skin care, Botox for masseter prominence reduction, and more.

A recent clinical trial compares 3 preparation systems used in fat grafting to examine efficiency.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of May.

While regenerative medicine is still in its infancy, patient demand and ease of use are growing its popularity among aesthetic physicians. However, regulatory issues raise concerns.

In this special edition of our "Meet the Aesthetic Expert" column, Will Kirby, DO, FAOCD, talks with board-certified, fellowship-trained dermatologist Deanne Mraz Robinson, MD, about her just announced role as chief medical officer of Ideal Image, the struggles regarding BDD patients, and the expanding role of allied healthcare providers.

A recent phase 2b study shows onabotulinumtoxinA is safe and effective in treating Masseter Muscle Prominence.